Sulfamethoxypyridazine

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Sulfamethoxypyridazine" – news · newspapers · books · scholar · JSTOR (June 2021) (Learn how and when to remove this template message)

Sulfamethoxypyridazine

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01ED05 (WHO) QJ01EQ15 (WHO)
Identifiers
IUPAC name 4-amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
JSmol)	Interactive image
SMILES O=S(=O)(Nc1nnc(OC)cc1)c2ccc(N)cc2
InChI InChI=1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) Y Key:VLYWMPOKSSWJAL-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Sulfamethoxypyridazine is a

It is also used in the treatment of Dermatitis herpetiformis,^[2] where it is an alternative therapy to Dapsone.

Sulfamethoxypyridazine is supplied as 500mg tablets.

References

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e